Chicago Capital’s Teladoc Health TDOC Stock Holding History

Chicago Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,699	Closed	-$339K	–	256
2022 Q1	$339K	Buy	4,699 +108	+2%	+$7.78K	0.01%	204
2021 Q4	$422K	Hold	4,591	–	–	0.02%	195
2021 Q3	$582K	Buy	4,591 +646	+16%	+$94K	0.02%	168
2021 Q2	$656K	Hold	3,945	–	–	0.03%	152
2021 Q1	$717K	Sell	3,945 -15,755	-80%	-$3.65M	0.03%	136
2020 Q4	$3.94M	Sell	19,700 -15	-0.1%	-$3.05K	0.18%	60
2020 Q3	$4.32M	Sell	19,715 -5,375	-21%	-$1.14M	0.22%	56
2020 Q2	$4.79M	Hold	25,090	–	–	0.28%	53
2020 Q1	$3.89M	Buy	25,090 +360	+1%	+$41.9K	0.31%	55
2019 Q4	$2.07M	Sell	24,730 -470	-2%	-$35.8K	0.13%	79
2019 Q3	$1.71M	Hold	25,200	–	–	0.11%	84
2019 Q2	$1.67M	Hold	25,200	–	–	0.11%	85
2019 Q1	$1.4M	Hold	25,200	–	–	0.1%	92
2018 Q4	$1.25M	Hold	25,200	–	–	0.1%	90
2018 Q3	$2.18M	Sell	25,200 -2,000	-7%	-$143K	0.15%	67
2018 Q2	$1.58M	Buy	27,200 +3,100	+13%	+$151K	0.13%	83
2018 Q1	$971K	Buy	+24,100	New	+$910K	0.13%	82

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Chicago Capital's TDOC Position: Q2 2022 in Review

Chicago Capital sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,699 shares — an estimated $339K sold.

Chicago Capital first reported a position in TDOC in Q1 2018 and held it in 17 quarters. The position peaked at $4.79M in Q2 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Chicago Capital reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Chicago Capital sold 4,699 Teladoc Health shares in Q2 2022, an estimated $339K.
Chicago Capital first reported a position in Teladoc Health in Q1 2018 and held it in 17 quarters.
Chicago Capital's Teladoc Health position peaked at $4.79M in Q2 2020.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Chicago Capital's 13F filing for Q2 2022, filed 21 Jul 2022.